Breaking News
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024

This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the c...

read more
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
September 05, 2024
European Commission Approves Akantior as First Treatment for Acanthamoeba Keratitis

The European Commission (EC) has officially approved Avanzanite Bioscience's Akantior (polihexanide)...

read more
European Commission Approves Akantior as First Treatment for Acanthamoeba Keratitis
September 02, 2024
ViaLase Laser Receives CE Mark Approval for Glaucoma Treatment

ViaLase has received CE Mark approval in the European Union for its ViaLase laser, designed to treat...

read more
ViaLase Laser Receives CE Mark Approval for Glaucoma Treatment
July 31, 2024
Bausch + Lomb Acquires Trukera Medical to Enhance Surgical Capabilities

Bausch + Lomb has completed the acquisition of Trukera Medical, a US-based ophthalmic medical diagno...

read more
Bausch + Lomb Acquires Trukera Medical to Enhance Surgical Capabilities
July 24, 2024
Oertli Instrumente Receives FDA Clearance for Faros Anterior Cataract Surgery System

Oertli Instrumente AG announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

read more
Oertli Instrumente Receives FDA Clearance for Faros Anterior Cataract Surgery System
July 24, 2024
Genentech to Reintroduce Susvimo Ocular Implant for Wet AMD

Genentech announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL for intravitreal...

read more
Genentech to Reintroduce Susvimo Ocular Implant for Wet AMD
July 17, 2024
Outlook Therapeutics Receives UK Approval of Lytenava for Wet AMD Treatment

Outlook Therapeutics announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA...

read more
Outlook Therapeutics Receives UK Approval of Lytenava for Wet AMD Treatment
July 16, 2024
Novo Nordisk’s Popular Weight Loss Drugs Linked to Higher Risk of NAION

A recent study by Mass Eye and Ear links semaglutide (Ozempic, Wegovy) from Novo Nordisk to higher N...

read more
Novo Nordisk’s Popular Weight Loss Drugs Linked to Higher Risk of NAION
July 04, 2024
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®

Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Adminis...

read more
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®
July 03, 2024
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication

Roche announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medic...

read more
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication
July 02, 2024
More